Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (73)	3/3/1997 12:45:00 AM
From: Troll_29	of 1127

Thanks for the comments. I believe this is an important consideration relative to HGSI. The earlier postings on this thread indicating developments by U of W / Merck have made HGSI's database of little or no value overlooks many issues that relate to arriving at a realistic valuation of HGSI -- but the stock has dropped recently and is quite volatile. Can anyone compare HGSI, INCY, and MDLI -- I understood HGSI had the superior product but the increase in stock price has been for INCY... The relationship between TIGR and HGSI also is not entirely clear to me. Any insight would be appreciated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next